Jyong Biotech Ltd.
MENS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001954488
No open-market purchases or sales by Jyong Biotech Ltd. insiders were filed in the last 90 days; 19 institutions reported holding it in 13F filings for Q2 2026, worth $1.01M in total; no superinvestor holds it.
13F holders, Q1 2026
Institutional positions in Jyong Biotech Ltd. as of Mar 31, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −2 vs. Q4 2025
- Shares held
- 453.6K
- −237.3K (−34.3%) vs. Q4 2025
- Total value
- $974.0K
- −$1.76M (−64.3%) vs. Q4 2025
- New holders
- 4
- 6 more added
- Sold out
- 6
- 7 more reduced
Compare with Q4 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MENS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 19 | $1.01M |
| Q1 2026 | 17 | $974.0K |
| Q4 2025 | 19 | $2.73M |
| Q3 2025 | 8 | $4.15M |
| Q2 2025 | 2 | $781.2K |
| Q1 2025 | 0 | $0 |
| Q4 2024 | 0 | $0 |
| Q3 2024 | 0 | $0 |
| Q2 2024 | 0 | $0 |
| Q1 2024 | 0 | $0 |
| Q4 2023 | 0 | $0 |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2026
Shares, value and share of portfolio for each institution holding Jyong Biotech Ltd.; share changes are against Q4 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 266 | $1.00K | 0.00% | +266 | New |
| Bell Investment Advisors, Inc | 473 | $1.02K | 0.00% | +473 | New |
| GF Fund Management Co. Ltd. | 1,677 | $3.61K | 0.00% | +184+12.3% | Added |
| BNP Paribas Arbitrage, SA | 1,881 | $4.04K | 0.00% | +581+44.7% | Added |
| Citigroup Inc | 2,787 | $5.99K | 0.00% | −8,109−74.4% | Reduced |
| Mirae Asset Global Investments Co., Ltd. | 3,872 | $8.32K | 0.00% | +178+4.8% | Added |
| JPMorgan Chase & Co | 5,679 | $10.8K | 0.00% | −372−6.1% | Reduced |
| Barclays PLC | 5,189 | $11.2K | 0.00% | +1,649+46.6% | Added |
| Morgan Stanley | 6,301 | $13.5K | 0.00% | −21,812−77.6% | Reduced |
| HRT Financial LP | 11,767 | $25.0K | 0.00% | +11,767 | New |
| Tower Research Capital LLC (TRC) | 11,703 | $25.2K | 0.00% | +6,918+144.6% | Added |
| China Universal Asset Management Co., Ltd. | 13,173 | $28.3K | 0.00% | +784+6.3% | Added |
| JustInvest LLC | 13,927 | $29.9K | 0.00% | +13,927 | New |
| Millennium Management LLC | 14,590 | $31.4K | 0.00% | −25,668−63.8% | Reduced |
| UBS Group AG | 37,363 | $80.3K | 0.00% | −108,285−74.3% | Reduced |
| Geode Capital Management, LLC | 64,232 | $138.1K | 0.00% | −150−0.2% | Reduced |
| BlackRock, Inc. | 258,760 | $556.3K | 0.00% | −2,063−0.8% | Reduced |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −69,560−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −23,182−100.0% | Sold out |
| Man Group plc | 0 | $0 | 0.00% | −14,222−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −420−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −204−100.0% | Sold out |
| Cornerstone Financial Management LLC | 0 | $0 | 0.00% | −14−100.0% | Sold out |